Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection (Q80322140)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

Streptococcus pyogenes

object named as

Streptococcus pyogenes

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Shigetada Kawabata

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Hideaki Fujitaka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Takashi Uehira

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Yoshinobu Okuno

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Shigeyuki Hamada

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

21-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

2887-2893

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

Severe group A streptococcal infection and streptococcal toxic shock syndrome

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

A clinical and bacteriologic investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production, and genomic DNA fingerprints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Severe Invasive Group A Streptococcal Infections In Ontario, Canada: 1987-1991

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Capsular hyaluronic acid of group A streptococci hampers their invasion into human pharyngeal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Programmed cell death (apoptosis) in human monocytes infected by influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Bacterial Adherence to Virus-Infected Cells: A Cell Culture Model of Bacterial Superinfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Influenza vaccine, anti-influenza drugs, and rapid diagnosis in Japan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

The 1918 influenza virus: A killer comes into view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

inferred from DOI database lookup

7 January 2021

based on heuristic

Pulmonary antibacterial defenses during mild and severe influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.024

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.12.024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15246625%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference